Clinical Report: Evaluation of Axillary Staging in Breast Cancer Patients After Neoadjuvant Chemotherapy

Overview

This study evaluates the prognostic significance of various axillary staging metrics in breast cancer patients post-neoadjuvant chemotherapy. It compares the traditional pathological node staging (pN-staging) and lymph node ratio (LNR) systems to identify the most predictive nodal metric for survival.

Background

Accurate axillary staging is crucial for treatment planning in breast cancer, particularly after neoadjuvant chemotherapy (NAC), which can alter lymph node involvement. The pN-staging and LNR systems are commonly used to assess prognosis, yet their effectiveness in the context of NAC remains uncertain. Understanding which metrics best predict survival can guide clinical decisions and improve patient outcomes.

Data Highlights

No numerical data or trial data was provided in the source material.

Key Findings

• The study analyzed 169 breast cancer patients who underwent NAC and subsequent axillary evaluation.
• Pathological node staging (pN-staging) categorizes patients based on the absolute number of positive lymph nodes.
• The lymph node ratio (LNR) system assesses the ratio of positive to total excised lymph nodes.
• Multiple axillary metrics were evaluated for their association with post-NAC survival.
• The study aimed to identify which axillary metric had the strongest prognostic value.

Clinical Implications

Clinicians should consider both pN-staging and LNR when assessing prognosis in breast cancer patients post-NAC. Identifying the most predictive axillary metric can enhance treatment planning and patient counseling.

Conclusion

The findings underscore the need for further research to refine axillary staging systems in the context of neoadjuvant chemotherapy, aiming to improve prognostic accuracy and patient management.

References

1. European Radiology, 2024 -- Evaluating MRI Efficacy for Standardized Assessment of Lymph Nodes in Breast Cancer: Is Node-RADS Implementation Feasible?
2. European Radiology, 2023 -- Evaluating the Effectiveness of Node Reporting and Data System (Node-RADS) for Staging Regional Lymph Nodes in Gastric Cancer via CT Imaging
3. Frontiers in Surgery, 2026 -- Evaluation of Axillary Pathological Complete Response and Imaging Diagnostic Performance Following Neoadjuvant Chemotherapy in Breast Cancer: A Retrospective Single-Center Analysis
4. European Radiology, 2025 -- Assessment of Primary Tumour Changes on Breast MRI as an Indicator of Axillary Pathological Response in Patients Undergoing Neoadjuvant Chemotherapy for Breast Cancer
5. ASCO Special Articles, 2025 -- Sentinel Lymph Node Biopsy in Early Stage Breast Cancer: ASCO Guideline Update
6. Axillary Surgery in Breast Cancer: Evidence-Based De-escalation Across Upfront and Post-Neoadjuvant Settings - PMC
7. Prognostic value of metastatic lymph-node ratio and log-odds of positive nodes after neoadjuvant chemotherapy in breast cancer - PMC
8. ASCO Special Articles
9. Axillary Surgery in Breast Cancer: Evidence-Based De-escalation Across Upfront and Post-Neoadjuvant Settings - PMC
10. Prognostic value of metastatic lymph-node ratio and log-odds of positive nodes after neoadjuvant chemotherapy in breast cancer - PMC